Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
Tomohiro Ueda, Philip M. Hanno, Ryoichi Saito, Jane M. Meijlink, Naoki Yoshimura
Int Neurourol J. 2021;25(2):99-110.   Published online 2021 Jun 30
DOI: https://doi.org/10.5213/inj.2142084.042
Citations to this article as recorded by
  Crossref logo
Female pelvic organ‐preserving robot‐assisted simple cystectomy and intracorporeal ileal neobladder reconstruction on a young woman with Hunner‐type interstitial cystitis
Hiroyuki Oue, Shiori Miyachi, Shinichiro Higashi, Takeshi Sasaki, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Katsunori Uchida, Tomohiro Ueda, Takahiro Inoue
IJU Case Reports.2024; 7(1): 73.     CrossRef
Analgesic Effect of the Kampo Formula Yokukansan via the Suppression of Substance P in an Experimental Rat Model of Hunner-Type Interstitial Cystitis
Yoshiki Tsunokawa, Mana Tsukada, Tatsuki Inoue, Masashi Tamaoka, Toshiki Mugita, Oyunchimeg Chuluunbat, Yoshiko Maeda, Takashi Fukagai, Yoshio Ogawa, Masataka Sunagawa
Cureus.2024;[Epub]     CrossRef
The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans
Elisabetta Mormone, Antonio Cisternino, Lorenzo Capone, Eugenio Caradonna, Andrea Sbarbati
International Journal of Molecular Sciences.2024; 25(4): 2326.     CrossRef
Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype
J. Curtis Nickel, Tiziana Cotechini, R. Christopher Doiron
Pathogens.2024; 13(5): 396.     CrossRef
Wnt/β-catenin signaling inhibits oxidative stress-induced ferroptosis to improve interstitial cystitis/bladder pain syndrome by reducing NF-κB
Weilin Fang, Xin Song, Hailong Li, Fanguo Meng, Tingting Lv, Jin Huang, Xiang Ji, Jianwei Lv, Zhikang Cai, Zhong Wang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; : 119766.     CrossRef
Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodology
Rajesh Taneja, Sanjay Pandey, Shivam Priyadarshi, Apul Goel, Amita Jain, Ranjana Sharma, Navita Purohit, Vidya Bandukwalla, Tanvir, Meera Ragavan, Amit Agrawal, Amit Shah, Zeenie Girn, Vikky Ajwani, Uttam Mete
International Urogynecology Journal.2023; 34(6): 1165.     CrossRef
Efficacy of Pudendal Nerve Blocks and Ultrasound-Guided Superior Hypogastric Plexus Blocks for the Management of Refractory Interstitial Cystitis: A Case Series
Arun Kalava, Matthew Crowley, Gina Parsonis, Lucas Wiegand
Cureus.2023;[Epub]     CrossRef
Animal models of interstitial cystitis/bladder pain syndrome
Cindy Tay, Luke Grundy
Frontiers in Physiology.2023;[Epub]     CrossRef
The O'Leary‐Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP‐116D, 5
Naoki Yoshimura, Takashi Uno, Mitsuru Sasaki, Akira Ohinata, Shigeki Nawata, Tomohiro Ueda
International Journal of Urology.2022; 29(4): 289.     CrossRef
Editorial Comment to Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients
Tomohiro Ueda
International Journal of Urology.2022; 29(5): 413.     CrossRef
Identification of diagnostic serum biomarkers for Hunner‐type interstitial cystitis
Kazumasa Torimoto, Tomohiro Ueda, Masato Kasahara, Akihide Hirayama, Chie Matsushita, Yoshihiro Matsumoto, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Katsuya Aoki, Kiyohide Fujimoto
LUTS: Lower Urinary Tract Symptoms.2022; 14(5): 334.     CrossRef
WGCNA and molecular docking reveal key hub genes and potential natural inhibitor in interstitial cystitis/bladder pain syndrome
Kuiqing Li, Cong Lai, Cheng Liu, Zhuohang Li, Kaixuan Guo, Kewei Xu
International Urogynecology Journal.2022; 33(8): 2241.     CrossRef
Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules
Guldal Inal-Gultekin, Zeliha Gormez, Naside Mangir
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
Ioannis Mykoniatis, Stavros Tsiakaras, Michael Samarinas, Anastasios Anastasiadis, Evangelos N Symeonidis, Petros Sountoulides
Biologics: Targets and Therapy.2022; Volume 16: 47.     CrossRef
Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases
Justin Loloi, Mustufa Babar, Kelvin P. Davies, Sylvia O. Suadicani
Therapeutic Advances in Urology.2022; 14: 175628722211090.     CrossRef
Reply to “Interstitial Cystitis – A Consequence of Weakened Uterosacral Ligaments Failing to Support Visceral Plexuses and Bladder Stretch Receptors and Therefore Potentially Curable?”
Tomohiro Ueda
International Neurourology Journal.2022; 26(4): 352.     CrossRef
Interstitial Cystitis: A Consequence of Weakened Uterosacral Ligaments Failing to Support Visceral Plexuses and Bladder Stretch Receptors, and Therefore Potentially Curable?
Peter Petros
International Neurourology Journal.2022; 26(4): 349.     CrossRef
Editorial Comment from Dr Ueda to Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner’s lesion and grade 3 glomerulation might be different from other types o
Tomohiro Ueda
International Journal of Urology.2021; 28(8): 831.     CrossRef
Interstitielle Zystitis: Interventionelle und operative Therapie – mehr als eine Ultima Ratio
Thomas Bschleipfer, Björn Kaftan
Aktuelle Urologie.2021; 52(06): 561.     CrossRef
Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome
Saki Sultana, Geraint Berger, Christian Lehmann
Diagnostics.2021; 12(1): 19.     CrossRef